Boaz Weinstein’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Boaz Weinstein’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-368,429	Closed	-$3.68M	–	1018
2022 Q3	$3.68M	Hold	368,429	–	–	0.04%	572
2022 Q2	$3.63M	Buy	368,429 +13,586	+4%	+$134K	0.04%	583
2022 Q1	$3.49M	Buy	354,843 +121,871	+52%	+$1.2M	0.05%	499
2021 Q4	$2.27M	Buy	232,972 +10,693	+5%	+$105K	0.03%	509
2021 Q3	$2.18M	Hold	222,279	–	–	0.05%	356
2021 Q2	$2.15M	Buy	222,279 +72,579	+48%	+$707K	0.06%	278
2021 Q1	$1.45M	Buy	+149,700	New	+$1.45M	0.05%	267

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Boaz Weinstein's PKBO Position: Q4 2022 in Review

Boaz Weinstein sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 368,429 shares — an estimated $3.68M sold.

Boaz Weinstein first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $3.68M in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Boaz Weinstein reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Boaz Weinstein sold 368,429 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $3.68M.
Boaz Weinstein first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Boaz Weinstein's Peak Bio, Inc. Common Stock position peaked at $3.68M in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.